Associate Director, Biomarker Strategy (Neuroscience)

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Discovery & Pre-Clinical/Clinical Development

Job Sub Function:

Translational Discovery & Development Biomarkers

Job Category:

Scientific/Technology

All Job Posting Locations:

Boston, Massachusetts, United States of America, San Diego, California, United States of America, Spring House, Pennsylvania, United States of America, Titusville, New Jersey, United States of America

Job Description:

Johnson & Johnson, is recruiting for a Associate Director, Biomarker Strategy (Neuroscience) to be based at one of our sites in San Diego, CA; Titusville, NJ; Spring House, PA; or Boston, MA.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Neuroscience team tackles the world’s toughest brain health challenges including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, epilepsy, major depressive disorder, bipolar disorder, schizophrenia, and autism. This patient-focused team helps address some of the most complex diseases of our time.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Neuroscience Precision Measures (PM) Team is an integrated scientific organization supporting the delivery of precision therapeutics to patients with CNS disorders across neuropsychiatry, neurodegeneration, and ophthalmology. The team brings together disease experts, biomarker scientists, computational biologists, and leaders in imaging and digital health, and partners closely with Neuroscience Discovery and Development organizations to advance an industry‑leading portfolio of novel mechanisms.

Precision Measures advances measurement science grounded in human data—including fluids, tissues, high‑dimensional biology, and neuroimaging—to support the end‑to‑end portfolio. In close collaboration with internal and external partners, the organization delivers decision‑enabling insights spanning target selection, early and late clinical development, regulatory submissions, and post‑market evidence generation.

The Associate Director, Biomarker Strategy is a senior individual‑contributor to shape and drive biomarker strategy across clinical development phases. Reporting to the Head of Quantitative Imaging and Clinical Biomarkers, this role has primary responsibility for defining and delivering endpoints that enable patient screening, stratification, and evidence generation to inform development, portfolio, and regulatory decisions.

Operating with minimal direction, the incumbent leads biomarker efforts spanning disease areas and measurement modalities. The role requires independent scientific judgment, deep quantitative expertise, and strategic influence to develop study design and address scientific questions that impact compound‑ and portfolio‑level decisions. The incumbent serves as a key scientific authority on Compound Development Teams and contributes to internal governance through biomarker strategies, evidence packages, and expert input.

Key Responsibilities:

• Serve as a leader for imaging and biomarker strategy, partnering to drive alignment, rigor, and execution.

• Define, develop, and operationalize clinical trial biomarker plans, including screening funnels, patient stratification, and endpoint strategies, ensuring fit‑for‑pu